Shiqi Huang holds a Ph.D. from West China School of Pharmacy, Sichuan University, China. She is an associate researcher at the College of Polymer Science and Engineering, Sichuan University, working under Professor Ling Zhang. Her research focuses on improving the disease process of ischemic stroke and other life-threatening conditions. She has received support from the National Science Fund for Young Scholars, the National Fund for Postdoctoral Research Projects, the No.75 General Fund of the China Postdoctoral Science Foundation, and the Science Fund for Young Scholars of Sichuan Province.
Profile
Education 🎓
Shiqi Huang completed her Ph.D. at the West China School of Pharmacy, Sichuan University, China. Her academic training provided a strong foundation in drug delivery systems and nanomedicine. Her research explored novel nanocarriers for targeted therapy and combination treatments, contributing to advancements in biomedical sciences. Her studies were supported by national and provincial funding bodies, recognizing her potential in pharmaceutical research.
Experience 👨🏫
Dr. Huang serves as an associate researcher at the College of Polymer Science and Engineering, Sichuan University. She actively contributes to research under Professor Ling Zhang’s group, focusing on targeted drug delivery and nanotechnology. She has played a crucial role in projects funded by prestigious organizations, collaborating on translational research aimed at developing innovative therapeutic strategies. Her work extends beyond academia, impacting biomedical applications through interdisciplinary approaches.
Research Interests 🔬
Dr. Huang specializes in drug delivery systems and targeted nanomaterials. Her research explores novel nanocarriers for cancer therapy, ischemic stroke, and other diseases. She has contributed to high-impact publications in SCI journals such as Advanced Materials, Journal of Controlled Release, and European Journal of Medicinal Chemistry. Her studies aim to enhance the efficacy and safety of therapeutic agents through precision medicine and nanotechnology
Awards & Recognitions 🏅
Dr. Huang has received multiple prestigious grants and awards, including the National Science Fund for Young Scholars, the National Fund for Postdoctoral Research Projects, the No.75 General Fund of the China Postdoctoral Science Foundation, and the Science Fund for Young Scholars of Sichuan Province. These honors highlight her contributions to pharmaceutical sciences and her commitment to advancing medical research through innovative drug delivery strategies.
Publications
- 1．Shiqi Huang, Yining Zhu, Ling Zhang*, and Zhirong Zhang. Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Advanced Materials, 2021: 2107946.2．Shiqi Huang, Yicong Zhang, Luyao Wang, Wei Liu, Linyu Xiao, Qing Lin, Tao Gong, Xun Sun, Qin He, Zhirong Zhang, and Zhang Ling*. Improved Melanoma Suppression with Target-delivered TRAIL and Paclitaxel by a multifunctional Nanocarrier. Journal of Controlled Release, 2020,325:10-24.3．Shiqi Huang, Lang Deng, Hanming Zhang, Luyao Wang, Yicong Zhang, Qing Lin, Tao Gong, Xun Sun, Zhirong Zhang*, and Ling Zhang*. Co-delivery of TRAIL and paclitaxel by fibronectin-targeting liposomal nanodisk for effective lung melanoma metastasis treatment. Nano Research, 2022, 15(1): 728-737.
4．Shiqi Huang, Hanming Zhang, Yicong Zhang, Luyao Wang, Zhirong Zhang, and Ling Zhang*. Comparison of two methods for tumour-targeting peptide modification of liposomes. Acta Pharmacologica Sinica, 2023, 44(4): 832-840.
5．Hanming Zhang, Honglin Gao, Yicong Zhang, Yikun Han, Qing Lin, Tao Gong, Xun Sun, Zhirong Zhang, Ling Zhang*, and Shiqi Huang*. Enzyme-activatable disk-shaped nanocarriers augment tumor permeability for breast cancer combination therapy. Nano Research, 2024: 1-11.
6. Jiaxi Han, Haozhou Shu, Ling Zhang*, and Shiqi Huang*. Latest advances in hydrogel therapy for ocular diseases. Polymer, 2024, 306: 127207.